Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma
Clinical trial NCT00006243 · COMPLETED
Trial details
- NCT number
- NCT00006243
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2006-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.